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Abstract
This paper considers the problematic role of the
science–media symbiosis in the dissemination of mis-
leading and emotionally manipulative information re-
garding services o¤ered by CordBank, New Zealand’s
only umbilical cord blood banking facility. As this
case study illustrates, the growing reliance of health
and science reporters on the knowledge capital of
medical specialists, biogenetic researchers, and scien-
tists potentially enhances the ability of ‘expert’ sources
to set the agenda for media representations of emerging
medical and scientific developments, and may under-
mine the editorial independence of journalists and edi-
tors, many of whom in this case failed to critically eval-
uate deeply problematic claims regarding the current
and future benefits of cord banking. Heavy reliance
on established media frames of anecdotal personaliza-
tion and technoboosterism also reinforced a pro-
science journalistic culture in which claims by key
sources were uncritically reiterated and amplified, with
journalistic assessments of the value of cord banking
emphasizing potential benefits for individual consum-
ers. It is argued that use of these media frames poten-
tially detracts from due consideration of the broader
social, ethical, legal, and health implications of emerg-
ing biomedical developments, along with the pro-
fessional, personal, and increasingly also financial
interests at stake in their public promotion, given the
growing commercialization of biogenetic technologies.
Keywords: science journalism; science–media symbio-
sis; stem cells; cord banking; anecdotal personaliza-
tion; technoboosterism.
1. Introduction
In March 2005, New Zealand’s Metro magazine pub-
lished a detailed expose´ alleging factual inaccura-
cies, misrepresentations, and emotionally manipula-
tive content in the promotional materials and public
representation of New Zealand’s only (privately
owned) umbilical cord blood banking facility, Cord-
Bank (Philp 2005). Drawing heavily on a paper con-
currently published in the New Zealand Medical
Journal by Sullivan et al. (2005), Metro’s expose´ is
remarkable for two reasons. First, because it was
heavily dependent on this local scientific critique as
opposed to the more traditional investigative journal-
ism on which this magazine’s reputation is based. In
part, this reflects the growing reliance of journalists
on the knowledge capital of those actively engaged
with emerging medical and scientific developments,
and raises a number of critical questions regarding
the nature, conduct, and content of science and health
reporting within contemporary mediascapes. Second,
this article is remarkable because it was so long in
coming. Christchurch pediatric oncologist Dr. Mi-
chael Sullivan had publicly raised a number of con-
cerns about CordBank’s claims as early as June
2002. These were quickly sidelined in favor of media
coverage that was largely upbeat and positive, and
which enthusiastically reiterated misleading informa-
tion about the actual and potential therapeutic bene-
fits of banking umbilical cord blood.
In this paper, I suggest that print media coverage
of CordBank can be understood as a product of the
(biomedical) science–media symbiosis, and illustrate
how CordBank’s promoters were able to utilize local
media for public relations purposes, to such an extent
that local journalists continued to restate and indeed
amplify inaccurate and deceptive claims about the
nature and value of CordBank’s services in the face
of growing local and international criticism of private
autologous cord banking. I suggest that the ability
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of certain ‘expert’ sources to publicly misrepresent,
under the guise of news, the actual and potential
applications of autologous cord banking for potential
commercial gain is the predictable outcome of a ‘con-
cordance of interest’ (Condit 1994) between journal-
ists and medical and scientific professionals, a small
but growing number of whom are simultaneously bio-
medical entrepreneurs. The analysis o¤ered here thus
draws on a theoretical understanding of the increas-
ingly problematic symbiosis between medical special-
ists, scientists, and media professionals in Western
capitalist nations; a symbiosis which I suggest clearly
operates in the New Zealand context.
2. The science–media symbiosis
While much of the more relevant literature pertains
to other national contexts, local research suggests
broadly similar processes are likely to occur here, par-
ticularly given the highly commercialized nature of
New Zealand media production and significant for-
eign ownership (Bell 1995). As Lealand (2004) notes,
New Zealand is e¤ectively ‘media-saturated’, with a
large number of metropolitan and provincial daily
newspapers, free community papers, and local maga-
zines. Newspaper ownership is heavily concentrated
in the hands of Fairfax New Zealand Ltd. (owned by
John Fairfax Holdings Limited of Australia), or APN
New Zealand Ltd., also Australian owned. Most ma-
jor magazine titles are owned by Kerry Packer’s Aus-
tralian Consolidated Press. With few exceptions, local
media operate according to commercial imperatives.
Print media outlets in particular face intense competi-
tion for readership and advertising, with many daily
newspapers facing declining circulation and increased
competition from free suburban papers (Lealand
1998).
These di‰culties are compounded by significant
understa‰ng in many newsrooms. Regular national
surveys of New Zealand journalists suggest a femi-
nized and comparatively youthful local workforce
(Lealand 1998, 2004). While 60% of local journalists
have completed a university degree, most degrees were
in the arts or social sciences, and only 7% of these were
Masters degrees (Lealand 2004). The dwindling num-
ber of senior journalists has sparked concerns about
declining skill levels and journalistic standards, loss
of institutional memory, and a lack of critical acumen
within the profession as a whole (Lealand 2004). A
lack of resources is also seen to contribute to editorial
policies discouraging in-depth investigation of com-
plex issues, along with greater reliance on New Zea-
land Press Association stories, freelance journalism,
and syndicated features. Increased competition and
commercial pressures are further held to contribute
to the ‘dumbing down’ of news stories, and a blur-
ring of distinctions between news and entertainment.
Many senior journalists are concerned about the im-
plications of these trends for editorial independence,
and for the maintenance of journalistic principles
of accuracy, balance, and objectivity (Lealand 1998,
2004). Sixty-seven percent of journalists surveyed in
2003 agreed that local journalism was unduly influ-
enced by corporate ownership and by the needs of
advertisers (Lealand 2004: 193). These trends are not
dissimilar to those identified in other national con-
texts where media are heavily commercialized, sug-
gesting that existing research may bear considerable
relevance locally.
Numerous scholars have noted that the selection,
framing, and organization of information presented
by news media are shaped both by the original
source(s), and by established journalistic codes and
conventions, news routines, and the professional and
economic imperatives underpinning commercial me-
dia production and circulation (Gans 1979; Gitlin
1980; Philo 1990, 1993; Schudson 1995; Conrad
1997). In terms of the former, journalistic conventions
require the use of credible and qualified authorities
as sources. Thus, the voices of highly qualified and
institutionally a‰liated specialist doctors, scientists,
and researchers are consistently privileged in health
and science news (Van Dijck 1995, 1998). This privi-
leged status reflects also that many journalists lack
advanced medical or scientific training in areas that
are rapidly evolving in extremely complex ways, and
so rely on these key sources for both a practical un-
derstanding of new developments, and for ‘clarifica-
tion’ of their nature, importance, and potential im-
plications (Dunwoody 1986; Friedman 1986; Nelkin
1987; Karpf 1988; Van Dijck 1995; Sweet 2003).
Consequently, scientists, medical specialists, and
medico-scientific organizations have become an espe-
cially powerful interest group that has considerable
input into the nature of media representations of
new developments in their field. Increasingly, group
members seek to influence news media by hiring com-
munications and public relations managers to handle
media interactions, issuing press releases highlighting
‘major breakthroughs’ or profiling new medical ser-
vices, providing journalists with information pack-
ages, establishing educational and promotional Web
sites, and actively lobbying journalists and editors to
cover issues in ways that uphold their interests (Fried-
man 1986; Nelkin 1987; Karpf 1988; Lewenstein
1995; Van Dijck 1998; Nisbet and Lewenstein 2002).
A classic example of such media management re-
cently occurred locally when public relations consul-
tants, Communication Trumps, tried to ‘engineer
public opinion’ by means of ‘propaganda and secrecy’
to e¤ectively cover up disturbing physical abnormal-
ities in salmon resulting from genetic modification
carried out by King Salmon (Weaver and Motion
2002: 341).
This active management of media representations
is especially vital for the biomedical/scientific project
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at this time to allay public anxieties over controver-
sial developments such as genetic modification, stem
cell research, and human cloning.1 As Weingart
(1998: 871) notes, ‘the stronger the dependence of
science on public consent, the more important is at-
tention and consent of the media.’ By cultivating pos-
itive relationships with media and carefully managing
the public representation of research and develop-
ment in their area, ‘media-savvy’ medical specialists,
scientists, and researchers are often able to garner
positive publicity that fosters public and o‰cial en-
thusiasm for their work, thereby helping to secure
funding (Dunwoody 1986; Nelkin 1987; Karpf 1988;
Petersen 2001).
In turn, news media are now heavily reliant on
information provided by o‰cial, institutional, and
other scientific sources, and frequently reproduce it
with little mediation (Candy 1982 and Soloshi 1989,
as cited in Nisbet and Lewenstein 2002; Logan 1991,
as cited in Petersen 2001; Sweet 2003). The highly
specialized nature of emerging biomedical develop-
ments means journalists are increasingly dependent
on reiterating the same terms, metaphors, images,
rhetorical strategies, and frameworks of understand-
ing used by scientists and medical specialists in relat-
ing the nature and value of their work (Nelkin 1987;
Van Dijck 1995; Petersen 2001). Hence, mainstream
media potentially serve as a conduit through which
scientists, medical specialists, and medico-scientific
organizations attempt to assert the legitimacy of, and
win consent to, their shared worldview or ‘regime of
truth’ (Foucault 1989 [1971]) by controlling how par-
ticular issues and new developments are represented
to the general public (see also Corner et al. 1990).2
By influencing the way new developments are discur-
sively framed and represented in media, these interest
groups exert considerable power over public and po-
litical responses to them. E¤ectively, they are often
able to set the agenda for subsequent discussion and
debate on their own terms. Once this agenda is set, it
becomes very di‰cult to shift the media focus and
broaden the parameters of the debate (Gitlin 1980;
Nisbet and Lewenstein 2002). Issues, critiques, and
voices of dissent that are marginalized or excluded
are unlikely to enter widespread public consciousness,
resulting in a ‘spiral of silence’ (Nisbet and Lewen-
stein 2002: 363) that ultimately favors a ‘consensus’
or hegemonic perspective.
While authoritative sources play a key role in fram-
ing the information they provide, journalistic codes
and conventions, news routines, professional train-
ing, and economic imperatives all impact upon the
mediation process. Science and health journalists
must ‘translate’ complex research findings and highly
technical details into simplified lay language, while
also producing an interesting and readable story that
has considerable ‘news value’ (Friedman 1986; Nel-
kin 1987; Lewenstein 1995). Industrial and profes-
sional constraints mean that stories often need to be
researched quickly and reported in just a few columns
(Dunwoody 1986; Karpf 1988; Weingart 1998). These
factors encourage journalists to rely on an existing
pool of established ‘expert’ sources and to construct
news stories that fit within established ‘media frames’
(Gitlin 1980; Nelkin 1987; Nisbet and Lewenstein
2002). Further, media privilege certain understand-
ings through determining the story’s ‘hook’ or angle,
by using particular words and metaphors that im-
plicitly convey a particular worldview, by allocating
greater space to certain speakers, and through the se-
lection of headlines, captions, and accompanying im-
ages (Gitlin 1980; Nelkin 1987; Nisbet and Lewen-
stein 2002).
Today’s news media are also in the business of tell-
ing and selling stories to a general audience. Deci-
sions about which ‘media frame’ or angle to adopt
are often informed by an underlying economic im-
perative of attracting and keeping readers, the basis
of considerable advertising revenue (Bell 1995; Wein-
gart 1998; Underwood 2001). This latter imperative
fuels an increasing reliance on ‘market-oriented’
and ‘soft news’ stories emphasizing sensation and
drama (Underwood 2001; Nisbet et al. 2003). In
the case of health and science reporting, complex
medical and scientific issues and debates are often
simplified into ‘human interest’ stories that require
less time to research and write and make for emotion-
ally compelling reading, helping boost sales (Cook
1998 and Patterson 2001, as cited in Nisbet et al.
2003).
This is reflected in the growing reliance on a media
frame that Nisbet et al. (2003: 48) term ‘anecdotal
personalization’, wherein the potential benefits and
implications of emerging biomedical treatments and
technologies are introduced and explored using the
personal testimony of individuals as the primary
frame of reference, in a way that Condit (1994) sug-
gests invites readers to identify with characters and
share in their personal struggles and triumphs. As
noted by Karpf (1988), Conrad (1997), and Petersen
(2001), anecdotal personalization is used to create in-
terest and make ‘high-tech’ procedures and technolo-
gies more relevant and personally meaningful to lay
audiences by demonstrating their value for particular
individuals. Problematically, however, this personal-
ized focus often occurs at the expense of detailed
technical information or contextualization of the is-
sues raised, and risks oversimplifying and poten-
tially misinforming the public about important de-
tails (Nisbet et al. 2003)—a point expanded upon
below.
Mainstream media also routinely exhibit a pro-
technology bias. Key sources, established news val-
ues, and professional routines all encourage reporters
to emphasize the positive benefits of new scientific
and biomedical developments, and to ‘overrate and
overhype ‘‘high-tech’’ solutions’, in a process some
refer to as ‘technoboosterism’ (Parrott and Condit
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1996: 8). Technoboosterish coverage typically repre-
sents medical and scientific research as progressive,
beneficial, and as o¤ering hope of imminent cures for
the sick and a¿icted. Often, purely hypothetical fu-
ture benefits of emerging technologies and treatments
are emphasized and celebrated as though they inev-
itably emerged from the unstoppable march of sci-
entific progress (Van Dijck 1995, 1998). Conversely,
as Petersen (2001: 1263) notes, ‘potential disadvan-
tages and dangers are either ignored or provide only
a minor sub-theme.’ It is also common for a small
number of positive research findings relating to the
therapeutic uses of stem cells in particular to be high-
lighted and then extrapolated or ‘telescoped’ (Parrott
and Condit 1996) to hypothetically encompass poten-
tial treatments for the full range of chronic and ge-
netic disorders, with journalists frequently reiterating
the unqualified declarative statements of a few cited
experts.
In this respect, traditional journalistic conventions
of objectivity and balance are less frequently ob-
served. As Nelkin (1987) suggests, science is often
regarded by journalists as ‘the ultimate authority’,
reflecting an underlying presumption that medico-
scientific knowledge is objective and entirely disinter-
ested, and thus that those conducting the research or
initiating a new health service can also legitimately
evaluate its importance and potential significance.
The failure of many journalists to acknowledge the
social, political, and economic contexts in which med-
ical and scientific research takes place means many
are literally unable to perceive the various ways in
which the self-reporting of specialists and scientists is
in fact often highly interested (Nelkin 1987; Weingart
1998; Sweet 2003). The increasingly close ties between
industry and research are infrequently acknowledged,
and journalists often fail to recognize key sources’
potential conflicts of interest (Moynihan 2000, as
cited in Sweet 2003). This lack of critical interroga-
tion of the aims, conduct, and interests underlying
much research ascribes medical specialists, scientists,
and researchers considerable leeway to shape the
agenda for how certain new developments are under-
stood and debated in the public domain (Karpf 1988;
Nelkin 1987).
Essentially a form of media bias, the absence of
critical evaluation largely reflects a symbiotic relation-
ship (Karpf 1988; Weingart 1998) between health and
science journalists and their most privileged sources.
As Condit (1994) notes, journalists rely on the knowl-
edge capital of medical specialists, scientists, and
researchers, both in order to report on new develop-
ments in their fields, and to maintain their journalistic
credibility. Newspaper and magazine editors and
owners also need to maintain and hopefully increase
the market share of their publications, the basis of
vital advertising revenue. The kinds of stories emerg-
ing from the ‘brave new world’ of reproductive and
biogenetic medicine are often inherently interesting,
topical, credible, and newsworthy. They make for
compelling reading, and help sell magazines and
newspapers.
For their part, journalists o¤er specialists and sci-
entists an avenue for public exposure and an opportu-
nity to shape public perceptions of their work and
its significance (Condit 1994). Stories about how a
particular research project or a given procedure may
one day prevent or cure disease, heal the impaired,
or end human su¤ering help facilitate public accep-
tance of even the most controversial research, and re-
assure legislators and funding agencies of its poten-
tial social and medical benefits. Such stories have the
added benefits of attracting consumer (and perhaps
also shareholder) interest and acceptance, potentially
fuelling market demand (Van Dijck 1995, 1998).
Thus, scientists and media personnel have a strong
concordance of interest in the positive representa-
tion of medical and biogenetic technologies (Condit
1994). It appears that in the case of CordBank,
this shared interest prevailed over journalistic integ-
rity and editorial independence, leading to unbal-
anced technoboosterish coverage and a lack of criti-
cal interrogation of CordBank’s deeply problematic
claims.
3. Methodology
The following discussion is informed by a detailed
narrative and discursive analysis of the full comple-
ment of regional and national print media coverage
devoted to CordBank since its launch in June 2002.
Twenty-five newspaper and magazine articles were
located using the electronic databases Index New
Zealand and NewsText Plus. The following analysis
also draws on the results of a larger-scale survey of
print media representations of reproductive and ge-
netic technologies conducted from 1 May 2002 to 1
September 2003, and from 1 August to 1 December
2004, which used the same databases to locate 170
texts, of which 32 specifically related to some aspect
of stem cell research and/or cord banking. Included
in this wider survey were the national daily paper,
The New Zealand Herald and Weekend Herald (cir-
culation 208,419; owned by APN New Zealand Ltd.);
the national weekly Sunday Star Times (210,898;
Fairfax Sundays), and three regional daily papers:
Christchurch’s The Press (90,828; Fairfax New Zea-
land Ltd.), the Wellington-based The Dominion Post
(98,229; The Dominion Post); and the Hamilton-
based Waikato Times (41,849; Fairfax New Zealand
Ltd.). Fairfax’s relative domination of print media
ownership in New Zealand means there was some
sharing of news stories and perspectives, with some
articles (re)presenting verbatim portions of previ-
ously published articles. Also included were four
high circulation magazines thought likely to contain
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relevant content: New Zealand Woman’s Weekly
(97,769; New Zealand Magazines Ltd.), New Zealand
Listener (75,177; New Zealand Magazines Ltd.),
Next magazine (66,836; ACP Media), and New Idea
(58,591; Pacific Magazines NZ).3
I should emphasize that this was not a study of me-
dia production, but rather of media representation, or
more specifically of the published outcomes of the in-
teractions between CordBank’s medical director and
promoters, its marketing and publicity materials (in-
cluding the CordBank Web site), selected clients who
publicly endorsed the service, local journalists, and to
a lesser extent, dissenting specialists. Thus, I have not
investigated the motivations or decision-making pro-
cesses of the journalists and editors who were specifi-
cally responsible for the stories that were published,
although I believe some insight can be gleaned from
the considerable body of research reviewed above,
and from the published texts themselves. Nor have
I specifically investigated the expectations, under-
standings, and decision-making processes of parents
choosing to utilize CordBank’s services. However,
given that client endorsements very frequently appear
within the media reports, the views of some parents
will be discussed. My primary focus remains, how-
ever, on the narrative framing and discursive repre-
sentation of CordBank in print media coverage of
this service.
On the basis of the results of both surveys, signifi-
cant evidence suggests that the science–media symbi-
osis encouraged most local journalists to actively pro-
mote CordBank’s services while marginalizing and
downplaying any critiques in favor of extensive anec-
dotal personalization and technoboosterism. Also ap-
parent is that this process was actively facilitated by
the considerable agenda-setting capacity of certain
prominent specialists and scientists in the New Zea-
land context.
4. Agenda-setting: A ‘specialist’ role
This capacity is openly acknowledged by local fertil-
ity ‘guru’ Dr Richard Fisher, a founding director of
New Zealand’s largest private fertility service pro-
vider, Fertility Associates, which also holds contracts
to deliver publicly funded treatment in several main
centers. Fisher can be regarded as the local equivalent
of British reproductive specialist and media celebrity
Professor Robert Winston, and has been profiled in
several newspaper and magazine articles over the
past ten years.4 While yet to host his own documen-
tary series, Fisher is perhaps New Zealand’s most
frequently cited medical specialist on a range of
issues, and evidently well aware of his ability to
shape public understandings of reproductive and re-
lated genetic technologies by actively ‘mediating’
their public representation, as the following remarks
indicate:
(1) (as cited in Hewitson 2004: A28; emphasis
added)
[I’ve] grown into this area, so I’ve watched it de-
velop and it’s under my control, in a sense. I have
two to three years to think about it before I sig-
nal it. You see, what I have done for the last 10
years is . . . raise it in the media, let everyone get
over their knee-jerk reactions. You get an oppor-
tunity to personalise it . . . . Most people say, ‘Oh
yuck, that’s not in the context of how I see the
world’ [referring to the use of pre-implantation
genetic diagnosis for sex selection]. Give them
three months to think about it and they can usu-
ally find someone in their peer group for whom it
might have been a good idea.
These are telling remarks given that, at this time,
Fertility Associates was awaiting ethical approval to
o¤er sex selection via pre-implantation genetic diag-
nosis, or PGD.5 They are also indicative of a par-
ticularly cozy (biomedical) science–media symbiosis
that permits prominent medical specialists involved
in commercial service delivery to set the agenda for
media representations of emerging biogenetic treat-
ments and technologies in terms of how they might
benefit the individual consumer. Indeed, this was pre-
cisely the predominant frame adopted by local media
in discussing the use of PGD for sex selection, as re-
flected in headlines such as ‘I would have loved to
have had a daughter’ (Catherall 2002a), ‘Genetic
screening new way to a healthy, balanced family’
(Catherall 2002b), and ‘Boy or girl . . . your choice?’
(Course 2003).
More recently, Dr. Mary Birdsall, Fisher’s col-
league and prote´ge´, has captured centre stage. De-
scribed by one reporter as ‘poised, [and] seemingly
media-trained’, Birdsall is fast becoming ‘the female
equivalent of the much-quoted Richard Fisher’ (Philp
2005: 52). In Winston, Fisher, and Birdsall, we see the
active personification of science as ‘The inherent be-
nevolence of technology is projected in the scientist
as a person’ (Van Dijck 1995: 66). As privileged ‘ex-
pert’ sources, these individuals are e¤ectively granted
the opportunity to utilize local media to direct atten-
tion toward the benefits and potential uses of new and
at times controversial lines of research and associated
technologies and services, and to shape public percep-
tions of emerging developments in the fields of repro-
ductive and biogenetic medicine. More problemati-
cally, given the growing commercialization of these
fields in New Zealand and elsewhere, Fisher’s and
Birdsall’s privileged status enables them to utilize
their symbiotic relationship with mainstream media
to extol the virtues of, and fuel consumer demand
for, expensive, medically nonessential services that
they themselves have developed, financed, and will
potentially profit from, with little (if any) critical in-
terrogation of claims made. This is precisely the situ-
ation that appears to have occurred with CordBank.
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5. ‘Selling’ CordBank: The role of media(ted)
fabrications
5.1. Background
CordBank, Australasia’s first dedicated umbilical cord
blood stem cell collection and storage facility, was es-
tablished in June 2002 by Birdsall, an obstetrician–
gynecologist experienced in the use of cryopreser-
vation through her work at Fertility Associates in
Auckland. It is one of a small number of ‘spin-o¤ ’
commercial ventures associated with this private fer-
tility service provider.6 Birdsall established CordBank
in partnership with Jenni Raynish, director of the
public relations consultancy firm, Raynish and Part-
ners, and the slick nature of its publicity, marketing,
and press materials reflects professional input. Cord-
Bank also has a small number of private shareholders
drawn from among Birdsall’s colleagues, family, and
friends (Philp 2005). It o¤ers a service in which um-
bilical cord blood is collected at the time of birth,
cryogenically preserved, and stored at an Auckland
facility in return for an initial outlay of NZ$4,300,
which includes the first 18 years of storage.
As something of an emerging medical and media
celebrity, Birdsall has featured actively promoting
her ‘brainchild’ in various newspaper articles, maga-
zine profiles, and in television appearances such as
TV3’s 20/20 program (see also Malcolm 2002; New
Zealand Health and Hospital 2002; Barton 2004).
News stories have also reported the uptake of Cord-
Bank’s services among regional communities, fre-
quently o¤ering the personal endorsements of local
users as well as the professional backing of Cord-
Bank’s medical advisor, Dr. Lochie Teague, clinical
director of hematology and oncology at Starship
Children’s Hospital, who is often cited stating that
the service ‘could definitely help save lives in the fu-
ture’ (Adams 2003: 3). Celebrity endorsement has
also been forthcoming from a local television person-
ality, Mary Lambie, whose daughter Grace was the
first baby to have blood stored at CordBank (Lynch
2002). It is also noteworthy that many of these news-
paper and magazine articles include details of how
to register by phoning 0800 CORDBANK or via the
Web site, and thus e¤ectively constitute free institu-
tional advertising in the guise of news (Van Dijck
1995).
Extensive publicity and marketing materials have
also been produced and widely disseminated, includ-
ing pamphlets distributed to medical centers, mid-
wifery clinics, and at antenatal classes. CordBank
services have also been marketed through displays at
Parent and Child Shows, and through its quarterly
newsletter, Safe&sound. Thanks to this extensive
public relations and marketing campaign, CordBank
has become firmly established as a four-million-dollar
business (Philp 2005). At the time of writing, how-
ever, not a single client has derived any benefit from
this service. Not one of over 2,400 stored cord blood
samples has been used (Hogan, A. [CordBank Com-
munications Manager], personal communication, 6
May 2005).
5.2. Obfuscating a crucial distinction
In order to understand the problem with how local
media have (mis)represented CordBank, it is neces-
sary to clarify the precise nature of the service it of-
fers. CordBank is audited and licensed by Medsafe,
a division of the Ministry of Health. Under its cur-
rent license and in accordance with the 1956 Health
Act, stem cells stored by CordBank can only be used
to treat the person from whom they are collected
through an autologous transplantation.7 However, al-
most all existing treatments using cord blood stem
cells (including many of those cited in CordBank pub-
licity materials) actually involve allogeneic transplan-
tation, using stem cells donated by a family member
or a matched but unrelated donor (European Com-
munities 2004). In the case of genetic disorders, this
is because the individual’s own stem cells are likely
to contain the same genetic defect causing the illness
being treated, and thus have no therapeutic value. In
other cases, such as leukemia, treatment harnesses the
graft versus leukemia e¤ect—caused by introducing
someone else’s immune system into the diseased
person—to enhance the e‰cacy of chemotherapy. As
Sullivan emphatically emphasizes, no specialist would
recommend an autologous stem cell transplant for
childhood leukemia (as cited in Philp 2005).
To date, there are only a dozen or so conditions in
which an autologous transplant might be used as part
of the treatment regime instead of a bone marrow
transfer, and in only one case would it be specifically
indicated—the very rare condition known as aplastic
anemia. Even in the few cases where an autologous
transplant might be indicated, however, cord blood
is unlikely to be the only potential source of stem
cells, as these can also be sourced from peripheral
blood or bone marrow (European Communities
2004; Sullivan et al. 2005). From the very outset,
however, CordBank was represented in ways that ob-
scured this crucial and absolute distinction between
autologous and allogeneic transplantation, and there-
by grossly ‘oversold’ the benefits of cord banking in
ways that appear to have misled journalists and cli-
ents alike.
5.3. Technoboosterism and the ‘hyping’ of cord
banking’s (dubious) benefits
This misrepresentation began from the very outset in
media coverage heralding the launch of CordBank,
with The New Zealand Herald devoting a full half-
page feature to an interview with Birdsall, pictured
smiling while holding a syringe used to extract
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umbilical cord blood, under the headline ‘Lifetime
guarantee’ (Malcolm 2002: G4). As the subheading
for this story exclaims, ‘Storing precious stem cells
from the cords of your newborns could save them
from distressing diseases of middle age.’ As noted by
Ericson et al. (1991), media are inclined to persist
with the interpretive frame originally assigned to a
particular story, even in cases where conflicting infor-
mation later comes to light. Given the number of sub-
sequent stories that draw on very similar terms and
phrases, this article appears to have enabled Birdsall
to set the agenda for subsequent media discussion of
CordBank, an agenda premised on inaccurate and
misleading claims regarding the actual and potential
benefits of the service currently on o¤er. In the text
of this story, Birdsall refers to the virtually bound-
less regenerative potential of stem cells as the ratio-
nale for cord banking, in a classic example of techno-
boosterism:
(2) (Birdsall as cited in Malcolm 2002: G4)
The reason for storing them is that cord-blood
stem cells provide the child, and then the adult,
with their own backup immune and blood sys-
tem. At present this can be used, without any
fear of rejection, to fight about 50 serious diseases
if they occur later in life. For instance, if a child
develops leukaemia the stem cells would be able to
be used instead of a bone marrow transplant . . .
feeding stored stem cells back into the blood is
a simple procedure with no dangers.
Here, Birdsall fudges the distinction between autolo-
gous and allogeneic stem cell treatments in a way
that neatly ‘telescopes’ the therapeutic benefits of the
latter to encompass the former. In the process, she
grossly overstates and indeed falsely represents the
current therapeutic uses of a person’s own stem cells,
erroneously suggesting these cells can be used to treat
every parent’s worst nightmare, childhood leukemia:
Feeding a person’s own stem cells back into their
blood has no curative potential in cases of childhood
leukemia. She goes on to make the questionable sug-
gestion that stem cell research is on the cusp of deliv-
ering even more remarkable therapeutic benefits:
(3) (Birdsall as cited in Malcolm 2002: G4; empha-
sis added)
The future of stem cells could be enormous.
There’s a huge amount of research going on
worldwide. In the not-too-distant future, stem
cells could be turned into brain cells, heart cells
or liver cells. If someone develops some disease,
such as Parkinson’s or Alzheimer’s, and they
have stored stem cells which express their own
DNA, they might be turned into replacement
tissue. . . ./. . . . More than 1500 cord blood trans-
plants have already been performed for a range of
illnesses.
Not only does Birdsall fail to note that virtually all of
the 1,500 transplants she cites involved allogeneic do-
nation (European Communities 2004; Sullivan et al.
2005), but she follows up a series of inaccurate and
speculative claims with the emotional clincher: since
‘The potential use for stem cells is going to be far
greater than it is now . . . storing them might mean the
di¤erence between the life and death of your baby in
future’ (Birdsall as cited in Malcolm 2002: G4; em-
phasis added).
Many of the articles subsequently published reiter-
ate similar claims, and state or strongly imply that
cord blood stem cells have numerous autologous
uses. For example, one story states that ‘Dr Birdsall
said umbilical cord blood was unusually rich in stem
cells that were an exact DNA match for the baby.
These stem cells could be used in the treatment of
many cancers and blood diseases by replacing diseased
cells with healthy stem cells’ (Batchelor 2003: 3;
emphasis added). Other articles routinely claim that
an individual’s own cord blood can be used in the
treatment of at least 45 life-threatening illnesses,
including leukemia, Hodgkin’s disease, lymphoma,
testicular cancer, multiple sclerosis, rheumatoid ar-
thritis, sickle-cell anemia, and some immune disorders
(Brooker 2002b; Gosgri¤ 2003; The New Zealand
Herald 2004). In reality, very few of the conditions
listed can be treated with a person’s own stem cells,
and in no cases is autologous transplantation of cord
blood stem cells specifically indicated (European
Communities 2004). It is important to note, however,
that local journalists did not merely repeat the errone-
ous claims of CordBank’s promoters. Many actively
amplified them by developing the ‘human interest’ an-
gle to further illustrate cord banking’s potential bene-
fits for individual consumers.
5.4. Anecdotal personalization, or ‘how cord
banking could help save your child’s life!’
As is often the case in media discussions of emerging
medical treatments and technologies, several articles
rely on extensive anecdotal personalization and pro-
vide detailed endorsements of CordBank from users
under headlines such as ‘Mother-to-be backs private
cordbank’ (Brooker 2002b: 3), ‘Oliver’s cord blood
banked for the future’ (The Timaru Herald 2003: 3),
‘Parents bank on a health plan for baby’ (Howick
and Pakuranga Times 2003: 4) and ‘Blood saved as
insurance’ (The Evening Standard 2003: 2). In these
and other stories, cord banking is represented at times
in an overwhelmingly positive way, with personal
testimony used as the primary frame of reference
‘guaranteeing’ its actual and potential value. Thus,
consumers attest to their desire not to miss this ‘once-
in-a-lifetime’ opportunity to save their child from
future su¤ering, while also revealing prevailing mis-
understandings of the actual and potential therapeutic
benefits of autologous cord banking:
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(4) (Unnamed woman su¤ering from rare blood
disorder, as cited in Brooker 2002b: 3)
‘My sister’s children have leukaemia on both
sides of their family’ . . . ‘If my daughter ends
up with the same condition as me, I want to be
able to cure her.’
(5) (Marie Cooper, mother, as cited in Batchelor
2003: 3)
‘It was the same principle as you buy any insur-
ance really. You buy your car insurance hoping
you’ll never need to use it but you have it there
anyway.’
(6) (Robbie Gerard, mother, as cited in The Timaru
Herald 2003: 3)
‘[I]f something did [go wrong] and we had had
the opportunity to do this and we hadn’t, then
we’d probably kick ourselves.’
(7) (Clair Belch, mother, as cited in Howick and
Pakuranga Times 2003: 4)
‘When I first heard about CordBank I read as
much as I could about cord blood banking
and decided I definitely wanted to take advan-
tage of this once-in-a-lifetime opportunity for
our baby’ . . . ./. . . . ‘I hope Charlotte never needs
to use this. But at least I know it will be there
for her should the unthinkable ever happen. It’s
given me peace of mind.’
The timing and very similar content of seven stories
published in regional newspapers within a few weeks
of each other over April/May 2003 illustrates the suc-
cess of CordBank’s promoters in defining the media
agenda. All exhibit extensive anecdotal personaliza-
tion in the form of testimony from a local couple (in
most cases with an accompanying photograph) who
describe the benefits they perceive in cord banking,
statistics on the uptake of cord banking in the local
region, details of the cost involved and the nature of
the procedure, and in all but one case, no reference
whatsoever to critiques of autologous cord banking
(Adams 2003: 3; Batchelor 2003: 3; Gosgri¤ 2003: 4;
Howick and Pakuranga Times 2003: 4; Nichols 2003:
3; Rankin 2003: 2; The Timaru Herald 2003: 3). These
common features, along with portions of identical
text in several of the articles (including the same ver-
batim quotations from Birdsall and Teague) clearly
suggest these stories were initiated, not by journalists,
but as part of CordBank’s ongoing public relations
campaign, most probably in the form of tailored press
releases issued to various regional newspapers, along
with the contact details of a local client willing to en-
dorse the service.
As an increasingly dominant media frame, anecdo-
tal personalization privileges the experiences and tes-
timony of individuals at the expense of in-depth inter-
rogation and critique. As is increasingly the case
with crime news (Ericson et al. 1991; Soothill and
Walby 1991), health and science stories are often
framed as personal concerns a¤ecting specific individ-
uals, rather than as public issues. Such media framing
in turn shapes public understandings of emerging
(bio)medical developments, their potential benefits,
e¤ects, limitations, and costs (Nelkin 1987; Conrad
1997; Petersen 2001; Nisbet and Lewenstein 2002).
In the media representation of CordBank, disease
was consistently framed as having genetic causes,
which can be circumvented by individuals (or rather,
their parents) taking out appropriate genetic health
‘insurance’ with a private service provider. In the
process, journalists failed to acknowledge that there
are rather more significant social and structural
causes of disease and ill health, along with important
social and ethical implications stemming from the
commercialization of health services that warrant
public discussion and debate. Evidently, such issues
did not fit with the established media frame and
agenda, and were thus excluded from the CordBank
story.
In the process of framing the CordBank story in
terms of anecdotal personalization, journalists also
uniformly failed to consider the wider economic and
political context in which this service has been o¤ered
and so actively promoted. This context is one marked
by sweeping reforms in the health sector during the
late 1980s and early 1990s, underfunding of the pub-
lic health system, privatization and commercializa-
tion of many nonurgent health services to the detri-
ment of public facilities, and resulting social inequities
in terms of a¤ordability and access. While umbilical
cord banking is hardly a health priority (given the
small number of individuals likely to benefit from it),
it should also be noted that the establishment of a pri-
vate facility serves to undermine the case for a far
more useful public allogeneic cord banking facility in
which stored blood could be more extensively used to
treat the donor, a blood relative, or matched recipient
(European Communities 2004; Sullivan et al. 2005).
Serious examination of these wider issues was e¤ec-
tively ‘crowded out’ by the focus on the personal tes-
timony of private individuals apparently convinced
that significant benefits may derive from banking
their children’s umbilical cord blood. In e¤ect, anec-
dotal personalization framed media discussions of
this service in a way that limited the kinds of ques-
tions that might be asked to just one: ‘how might
cord banking help save your child’s life in the future?’
Thus, the rather more important question of whether
the claims being made about the value of autologous
cord banking were themselves credible was placed
safely o¤ the media agenda.
Further, the predominant use of anecdotal person-
alization appears to have served an important func-
tion in terms of encouraging public acceptance of
cord banking, increasingly perceived by a significant
number of New Zealand parents as a useful and de-
sirable form of ‘health insurance’ (Philp 2005). Such
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acceptance appears largely due to the success of the
CordBank publicity machine in utilizing mainstream
media as well as other forms of advertising to assert
its preferred understanding of the service o¤ered. It
also appears that many local journalists and editors
have seen it as unnecessary to question the claims
made regarding cord banking’s actual and potential
benefits, perhaps because the personal endorsements
of users were routinely supported by two ‘expert’
medical commentators: Birdsall and Teague. The
fact that Birdsall clearly has professional as well as fi-
nancial interests at stake in CordBank’s commercial
success appears to have entirely eluded most local
journalists, and casts a shadow over her ascribed
‘impartiality’. Thus, rather than interrogating her
claims about CordBank as likely to be biased and
partial due to her status as a biomedical entrepreneur,
local media reiterated and amplified them. In head-
lines, subtitles, and captions, journalists and subedi-
tors drew on the same phrases, metaphors, and im-
ages used by Birdsall and in the endorsements of
those utilizing her service; in particular, the notion
that cord banking provides some kind of ‘future
proofing’ or ‘life insurance’. Clearly, many of those
using, publicly endorsing, and reporting on Cord-
Bank have been misled regarding its current and po-
tential applications, since few of the cited conditions
can in fact be treated via autologous transplanta-
tion, while future therapeutic options remain purely
speculative.
5.5. Media(ted) misperceptions: The role of the
CordBank Web site
Such misperceptions are hardly surprising given the
inaccurate and misleading nature of CordBank pub-
licity materials, including its Web site, a key source
of information for journalists as well as prospective
clients. Despite separate requests in October and
December 2004 to amend problematic information
(Philp 2005; Sullivan et al. 2005), this Web site con-
tinues to make highly emotive and deceptive claims
such as ‘saving your baby’s umbilical cord stem cells
could save your baby’s life’ and is ‘your only chance’
to provide them with ‘lifelong health insurance’
(http://www.cordbank.co.nz/why/). Such claims are
disputed by Sullivan et al. (2005), who note that cord
blood is by no means the ‘only’ nor even the most
desirable treatment for most of the conditions listed.
As they note, stem cells are not exclusively or
uniquely available in cord blood, and can also be
sourced from the patient’s own bone marrow, periph-
eral blood, or from a matched donor: ‘Very few life-
threatening conditions needing an autologous stem
cell transplant will specifically require cord blood de-
rived stem cells’ (Sullivan et al. 2005: para. 10). Fur-
ther, alternative existing treatments (such as chemo-
therapy, a bone marrow transplant from a matched
donor, or an allogeneic transplant of cord blood
imported from overseas) can in most cases achieve
the same ends. At the time of writing, CordBank pub-
licity neglects to mention all but one of these alterna-
tive treatment options,8 and continues to reiterate
misleading claims regarding the autologous uses of
stem cells under the dubious heading ‘Your only
chance’:
(8) (http://www.cordbank.co.nz/why/; emphasis
added)
Now you can provide your new baby with their
very own back-up immune and blood system.
Just by saving the blood from your baby’s um-
bilical cord, you’re giving your baby the chance
to survive some of the most deadly diseases and
debilitating conditions . . . . Because these stem
cells are compatible with your child’s immune
system, they can be used to fight more than 45
diseases, including leukaemia and Hodgkin’s dis-
ease, with no risk of rejection.
Elsewhere on this Web site, recent scientific develop-
ments utilizing allogeneic transplantation are used
to ‘substantiate’ the claim that ‘when you save your
baby’s cord blood stem cells you are giving your child
access to a huge number of potential future medical
treatments’ (http://www.cordbank.co.nz/experts/
articles.asp). Through a process of omission, distor-
tion, exaggeration, and misrepresentation of the ben-
efits of autologous cord banking, CordBank publicity
materials continue to imply that unless parents utilize
its services, their children may be deprived of their
‘one and only’ chance of surviving a range of debili-
tating diseases in later life.
In light of growing criticisms, links have recently
been added to separate pages that more clearly di¤er-
entiate between autologous and allogeneic uses of
cord blood stem cells (http://www.cordbank.co.nz/
why/diseases.asp), but this distinction continues to
be obscured in more prominent areas of the Web
site—as the above quote demonstrates.9 Further, Sul-
livan et al. (2005) argue that the techniques for col-
lecting and storing blood remain experimental, with
no evidence that stored cells will remain viable over
a person’s lifetime. This is an important point, since
several of the degenerative diseases cited in media
coverage as treatable with stem cells are unlikely to
appear until that person is in their sixties. In the
highly unlikely prospect that CordBank’s current fee
structure held static for 60 years, the cost of storing
cord blood until the time it is most likely to be needed
would be in excess of $10,000. A very high price to
pay for a very small chance of any benefit: Estimates
of the possibility that any particular individual will
benefit from the storage of their own cord blood
vary greatly, ranging from one chance in 5,000 (ac-
cording to CordBank) to a more conservative one in
200,000 (Sullivan et al. 2005). Added to that, there is
no guarantee that the small quantity of blood stored
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will even be su‰cient to treat a grown adult. Almost
without exception, local media failed to acknowledge
these crucial points.
5.6. The marginalization of dissenting voices
While the vast majority of media coverage has posi-
tively rea‰rmed the benefits of cord banking and the
value of (frequently hypothetical) stem cell therapies,
a handful did note the controversy raised by Sulli-
van’s initial criticisms of CordBank, originally pub-
lished in The Press in an article entitled ‘Baby-bank
doubts’ (Brooker 2002a). Here, Sullivan charged that
this facility was of dubious benefit given the very slim
chance of a child ever using his or her stored blood,
and risked ‘exploiting parental fear’ (Brooker 2002a:
1). This article also alludes to the misleading nature
of some of the claims made on the CordBank Web
site. However, the same journalist followed this story
up less than a week later with an enthusiastic endorse-
ment of CordBank from a prospective client (Brooker
2002b), in the process illustrating how anecdotal per-
sonalization increasingly serves to stifle much-needed
critical interrogation and debate through recourse
to the ultimate arbiter of value in contemporary capi-
talist societies—the individual consumer. Sullivan’s
criticisms are merely noted in passing in a few subse-
quent articles. Two of these also report the findings of
a British Royal College of Obstetricians and Gynae-
cologists study released in 2001, which concluded
that the routine commercial collection and storage of
blood from umbilical cords was not justified on scien-
tific grounds, and that it was speculative to suggest
stem cells might be used to cure a wide range of ill-
nesses. But rather than prompting further interro-
gation of CordBank’s claims, dissenting views are
merely included as a minor subtheme, and not devel-
oped further. A ‘spiral of silence’ gradually develops;
by 2003, any critique of CordBank is evidently o¤ the
media agenda, replaced by what can best be described
as PR spin.
Indeed, it wasn’t until March 2005 that the extent
of CordBank’s misrepresentation was publicly re-
vealed in Metro’s in-depth expose´ entitled ‘Cold com-
fort farm’ (Philp 2005), alleging factual inaccuracies,
along with misleading and confusing information
in CordBank promotional materials. This article also
notes that CordBank publicity overstates the number
and range of diseases and disorders for which a child’s
banked cord stem cells might currently be used to
treat that child, and is emotionally manipulative of
parents. Such views are supported by the European
Commission’s Group on Ethics in Science and New
Technologies (European Communities 2004), which
described private cord banking for autologous use as
having little current scientific value. As they note, the
chances of a donor’s own cord blood being used to
treat them are negligible:
(9) (European Communities 2004: 8–9; emphasis
added)
[I]ndications to store cord blood at birth in view
of a future autologous graft are for the present
time almost non-existent . . . . [I]t is not evident
that the use of patient’s own cord blood would
be preferable to the use of his/her own bone
marrow or to well-matched allogeneic stem cells
from donation. It is therefore highly hypothetical
that cord blood cells kept for autologous use will
be of any value in the future.
In their view, the endorsement of autologous cord
blood banking by medical doctors potentially raises
ethical issues of trust. They go on to suggest that the
misleading and inaccurate marketing of such services
risks preying on parental fear and guilt at a vulnera-
ble time. Burgio et al. (2003: para. 6) support this
view, and argue that ‘the promise of future autolo-
gous use seems unrealistic and deeply exploitative of
vulnerable new parents who have the economic means
to a¤ord it’. In 2002, the French National Consulta-
tive Ethics Committee o¤ered a somewhat harsher as-
sessment: ‘Such banks raise hopes of utopia and dis-
guise a mercantile project using assistance to children
as a screen’ (as cited in European Communities 2004:
15).
6. Some ethical considerations
As noted by Resnik (1998), medical specialists, re-
searchers, and scientists (including those involved in
commercial ventures) bear a particular professional
responsibility to ensure that the information they pro-
vide to journalists or in the form of advertising does
not misinform, deceive, or confuse the public, and
should ensure that principles of honesty, accuracy,
and social responsibility are upheld in all dealings
with media. This includes a special duty to avoid
misrepresentation, exploitation, and manipulation of
laypersons through making false claims or promoting
false or unrealistic hopes among the general public.
Similar sentiments have been formalized by the Amer-
ican College of Physicians, which takes the view that
advertising by physicians or medical institutions is
unethical ‘when it contains statements that are unsub-
stantiated, false, deceptive, or misleading, including
statements that mislead by omitting necessary infor-
mation’ (American College of Physicians 1998: 586).
Failure to observe these principles not only breaches
well-established medical and scientific ethics, but po-
tentially contributes to flawed policy decisions, mis-
guided public opinion, and misinformed decision-
making by individuals, with potentially considerable
economic and psychological costs (Resnik 1998).
In applying these ethical principles to the advertis-
ing and promotion of CordBank’s services, I submit
that many of the statements made by Birdsall and
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reported by local media were confusing, misleading,
and deceptive, and that several of the claims asserted
via the CordBank Web site remain ethically problem-
atic. In e¤ect, Birdsall utilized her privileged status as
an expert media source to disseminate, via main-
stream media and Internet, misleading information
about a commercial venture that she serves to profit
from. While Birdsall is just one of a growing number
of local physicians and scientists pursuing opportuni-
ties for biomedical entrepreneurialism, the fact that
she was engaged in a business venture does not exon-
erate her from the same ethical requirements borne by
other medical professionals and scientists. No matter
how fervently a scientist or medical specialist believes
in the positive potential of a particular service, treat-
ment, or therapy, he or she retains a number of
professional and ethical obligations with respect to
public communications about this matter—whether
these communications take the form of media state-
ments, press releases, or marketing and advertising
materials.
These obligations are, first, to accurately represent
and precisely specify the actual nature and applica-
tions of the service, treatment, or therapy on o¤er, as
currently permitted within the relevant regulatory
context; second, to openly and fully disclose all rele-
vant information regarding the dangers, limitations,
and possible e¤ects of a service, treatment, or ther-
apy; third, when discussing possible future applica-
tions of a service, treatment, or therapy, to make
clear that these are hypothetical as opposed to inevi-
table developments; fourth, to declare in all commu-
nications any financial interests in the commercial
success of the service, treatment, or therapy being
promoted; and fifth, to avoid acting in ways that are
or could be perceived as exploitative or manipulative
of the general public or media personnel, since as
Resnik (1998) notes, such behavior has the potential
to call their profession into disrepute should decep-
tion be subsequently exposed or insinuated.
More specifically in the case of the public promo-
tion and advertising of CordBank’s services, there is
a professional and ethical obligation to explicitly clar-
ify the crucial distinction between autologous and
allogeneic applications of stem cell therapy using um-
bilical cord blood; to explain the significance of this
distinction; to avoid presenting information in ways
that imply allogeneic and autologous therapies are
synonymous; to avoid emotionally manipulative mar-
keting claims that inaccurately represent the benefits
of banking cord blood; and to make clear that under
current New Zealand law, umbilical cord stem cells
can only be stored for future autologous use, and
that autologous stem cell transplantation in fact has
very limited therapeutic application.
While ethical breaches on the part of CordBank’s
founder and medical director clearly occurred in this
case, it is also concerning to note the role of local
journalists in actively perpetuating misleading and
manipulative information on behalf of CordBank,
and in failing to interrogate or critically assess the
claims made, despite early indications of their
problematic nature. The case of CordBank usefully
highlights the professional obligations of journalists
to remain objective, balanced, and accurate in their
reporting of the news, which should be clearly di¤er-
entiated from PR spin. Regardless of the professional
medical or scientific credentials of a source, and irre-
spective of the perceived value or worthiness of the
service, treatment, or therapy they are advocating,
journalistic integrity and independence should be
maintained. Journalists must also be mindful of the
rapidly changing spheres of science and medicine, in
which emerging possibilities for biogenetic entrepre-
neurialism generate clear conflicts of interest among
traditionally privileged ‘expert’ sources. These con-
flicts of interest must be explicitly acknowledged and
their implications explored. Now, more than ever, a
greater degree of journalistic integrity is necessary if
news media are to remain in the service of informing
the public rather than in the service of business, big or
small.
7. Conclusion
As this discussion of local media representations of
CordBank demonstrates, New Zealand print media
frequently echoed the very same terms, metaphors,
images, and frameworks of understanding used by
prominent medical specialists in promoting the value
of a service o¤ered on a private, commercial basis. In-
depth interrogation of the goals, benefits, costs, and
potential implications of private autologous cord
banking remained largely absent. Little, if any, criti-
cal attention was paid to the vested personal, pro-
fessional, and commercial interests at stake in this
venture, and very little of the coverage questions
Birdsall’s broader assertions regarding the ‘boundless
therapeutic potential’ o¤ered by stem cell research.
Rather than the media o¤ering balanced critical as-
sessment of CordBank’s claims and acknowledging
the interests of those so actively involved in its pro-
motion, a series of overblown, misleading, and emo-
tionally manipulative assertions were enthusiastically
reiterated and indeed amplified through the use of
media frames of anecdotal personalization and tech-
noboosterism. Once adopted, these frames militated
against due consideration of the actual nature, bene-
fits, and potential e¤ects of this new development.
While dissenting voices were initially acknowledged
in some articles, any critique of CordBank’s claims
was progressively marginalized and silenced within
mainstream media in favor of PR spin.
On the basis of this case study, it appears that the
symbiosis between local journalists and certain privi-
leged medical and scientific sources has the potential
to facilitate a process whereby key stakeholders are
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able to e¤ectively advocate in support of expensive,
nonessential medical services from which they poten-
tially profit. That, in the case of CordBank, they were
able to do so virtually unchallenged reflects the grow-
ing reliance of journalists on the knowledge capital of
established medical and scientific sources, along with
a related media bias favoring the positive represen-
tation of emerging medical and biogenetic research,
technologies, and treatments.
Considering the wider implications of the Cord-
Bank case, it could be argued that in providing a
conduit for the positive representation of emerging
medical and scientific developments by individuals
and groups that have clear professional and financial
interests at stake, media facilitate the process of discur-
sive normalization of controversial and in some cases
deeply problematic developments, lines of research,
and related commercial ventures. The science–media
symbiosis can thus be seen as enabling powerful inter-
est groups to define and delimit the nature and con-
tent of media representations on their own terms,
largely unchallenged, in a process that possibly aids
the further entrenchment of those (already hegem-
onic) interests within the wider public domain. By
actively celebrating the progress of medical science
and emphasizing the potential benefits of new devel-
opments and services for individual consumers, main-
stream media fail to provide an adequate forum for
much-needed public debate, interrogation, and cri-
tique of the nature, direction, social value, and grow-
ing privatization and commercialization of biogenetic
medicine.
Notes
1. Such research has sparked attempts to limit exploration
in controversial areas, as reflected in the Universal Dec-
laration on the Human Genome and Human Rights,
the Council of Europe Protocol to the Convention on
Biomedicine and Human Rights banning human re-
productive cloning, and the US-backed Costa Rican
proposal to ban all forms of human cloning, including
therapeutic, via the United Nations, tabled in October
2004.
2. While a ‘preferred’ reception cannot be guaranteed,
since readers may be able to draw on other sources of
knowledge such as personal experience and professional
expertise, the specialized nature of recent medical and
scientific developments means most people will lack
such alternative sources of information. Hence, the
media are likely to exert a major influence on public
understandings in this area.
3. All figures sourced on 1 May 2002, from The New Zea-
land Audit Bureau of Circulations Inc. (http://www.
abc.org.nz).
4. Two of these were published during the course of this
study: ‘This man has helped make more than 2000 ba-
bies’ (Fleming 2002), and ‘Up close and personal with
. . . Dr Richard Fisher: Fertile in mind and in soul’
(Hewitson 2004).
5. Despite Fisher’s best e¤orts to sway public opinion in
his favor, his proposal was rejected. It should be noted
that the regulation of PGD is governed by di¤erent
legislation to that governing CordBank. While the lat-
ter is licensed under the 1956 Health Act, the provi-
sion of PGD is now regulated by the Human Assisted
Reproductive Technology Act (2004), which restricts
its use to testing for genetic disorders and heritable
diseases.
6. In addition to o¤ering a full range of fertility services,
other ‘spin o¤ ’ businesses linked to Fertility Associates
include egg freezing (promoted to career women in
their 30s at a cost of $7000 plus annual storage fees
of $150) and Egg Check, for which a more modest
fee of $400 is charged (see Johnston 2004; Rowan
2004).
7. Any exception to this policy requires that special appli-
cation be made to the Ministry of Health for a dispensa-
tion. To date, no such dispensations have been granted.
8. Bone marrow transplantation is acknowledged, but
discounted as the ‘invasive’, ‘painful’, and frequently un-
successful counterpoint to painless and risk-free stem
cell transfusion, said to carry no risk of rejection be-
cause the cells are a ‘perfect match’—once again conflat-
ing autologous and allogeneic transplantation (http://
www.cordbank.co.nz/why/sct.asp).
9. In addition to altering some of its publicity material, the
growing pressure on CordBank has prompted two other
responses. First, a concerted push to change the law so
that stored cord blood can also be used in allogeneic
transplantations to treat immediate family members
(The New Zealand Herald 2005). Second, a rather canny
marketing strategy: since the current law only allows
stored blood to be used for autologous transfer, Cord-
Bank now explicitly recommends parents collect blood
for all of their children, and o¤ers a 15% discount for
the siblings of any baby who has already had their cord
blood stored. According to CordBank’s Communica-
tions Manager, a time-payment plan option is also in
the pipeline.
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